£2.0M
Epidarex Capital led the Series A round for the drug toxicity testing specialist.
CB
Clyde Biosciences
Clyde Biosciences develops technology to evaluate drug toxicity.
Glasgow, UK—Founded 2012
£2.0MTotal raised
Clyde Biosciences is a life sciences company originating from the University of Glasgow that evaluates drug toxicity for pharmaceutical developers.
Filed accounts
Cash at bank
Members only
Net assets
Members only
Shareholders' funds
Members only
Employees
Members only
Cash, assets and headcount from Clyde Biosciences's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Margaret Craig
Co-founder and CEO
Margaret brings commercial and strategy experience from roles at Alcyomics, Axol Bioscience, and Clyde Biosciences. She currently serves as chief executive officer of Stem Cell Technologies and Services alongside advisory work.
LinkedIn